Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • RESEARCH HIGHLIGHT

Deadly skin cancer can shrink or vanish after T cells join the fray

Immune-cell-based therapy quashed tumour growth in some people with treatment-resistant melanoma.
Coloured scanning electron micrograph of a cultured melanoma cell

A melanoma cell (artificially coloured). Treatment with descendants of a patient’s own immune cells can tamp down advanced melanoma. Credit: Steve Gschmeissner/Science Photo Library

A personalized anti-cancer treatment prolongs the amount of time that people with advanced melanoma live without further spread of their tumour, a clinical trial has shown1.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 612, 378 (2022)

doi: https://doi.org/10.1038/d41586-022-04337-5

References

  1. Rohaan, M. W. et al. N. Engl. J. Med. 387, 2113–2125 (2022).

    Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links